高级检索
    李龙芸, 周彩存, 张国淳. 非小细胞肺癌患者EGFR突变和基因扩增对吉非替尼疗效的预测价值[J]. 循证医学, 2006, 6(1): 23-27. DOI: 10.3969/j.issn.1671-5144.2006.01.008
    引用本文: 李龙芸, 周彩存, 张国淳. 非小细胞肺癌患者EGFR突变和基因扩增对吉非替尼疗效的预测价值[J]. 循证医学, 2006, 6(1): 23-27. DOI: 10.3969/j.issn.1671-5144.2006.01.008
    shu
    LI Long-yun, ZHOU Cai-chun, ZHANG Guo-chun. The Value of EGFR Mutation and Gene Amplification in Predicting Response to Gefitinib in NSCLC Patients[J]. Journal of Evidence-Based Medicine, 2006, 6(1): 23-27. DOI: 10.3969/j.issn.1671-5144.2006.01.008
    Citation: LI Long-yun, ZHOU Cai-chun, ZHANG Guo-chun. The Value of EGFR Mutation and Gene Amplification in Predicting Response to Gefitinib in NSCLC Patients[J]. Journal of Evidence-Based Medicine, 2006, 6(1): 23-27. DOI: 10.3969/j.issn.1671-5144.2006.01.008
    shu

    非小细胞肺癌患者EGFR突变和基因扩增对吉非替尼疗效的预测价值

    The Value of EGFR Mutation and Gene Amplification in Predicting Response to Gefitinib in NSCLC Patients

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回